Fresenius Medical Care AG (NYSE:FMS) shares gapped up before the market opened on Monday . The stock had previously closed at $44.47, but opened at $44.68. Fresenius Medical Care AG shares last traded at $45.26, with a volume of 115,349 shares changing hands.

A number of research analysts have commented on FMS shares. Jefferies Group raised Fresenius Medical Care AG from an “underperform” rating to a “hold” rating in a research report on Friday, July 8th. Berenberg Bank reaffirmed a “buy” rating on shares of Fresenius Medical Care AG in a research report on Tuesday, August 9th. Royal Bank Of Canada reiterated a “hold” rating on shares of Fresenius Medical Care AG in a report on Tuesday, May 24th. DZ Bank AG reiterated a “neutral” rating on shares of Fresenius Medical Care AG in a report on Thursday, August 4th. Finally, Zacks Investment Research upgraded Fresenius Medical Care AG from a “sell” rating to a “hold” rating in a report on Wednesday, May 4th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $42.50.

The company has a market cap of $27.69 billion and a P/E ratio of 25.10. The firm has a 50 day moving average of $45.10 and a 200-day moving average of $43.42.

Fresenius Medical Care AG (NYSE:FMS) last released its quarterly earnings results on Tuesday, August 2nd. The company reported $0.96 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.92 by $0.04. The company earned $4.42 billion during the quarter, compared to analysts’ expectations of $4.54 billion. Analysts forecast that Fresenius Medical Care AG will post $2.01 earnings per share for the current fiscal year.

A hedge fund recently raised its stake in Fresenius Medical Care AG stock. Bank of Montreal Can boosted its stake in Fresenius Medical Care AG (NYSE:FMS) by 60.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 56,700 shares of the company’s stock after buying an additional 21,264 shares during the period. Bank of Montreal Can’s holdings in Fresenius Medical Care AG were worth $2,373,000 as of its most recent SEC filing.

Fresenius Medical Care AG & Co KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end stage renal disease (ESRD), as well as other healthcare services. The Company operates through four segments: North America, Europe, Middle East, Africa (EMEA), Asia-Pacific and Latin America.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.